Hyzaar and Acute myeloid leukaemia aggravated - a phase IV clinical study of FDA data
Summary:
Acute myeloid leukaemia aggravated is found among people who take Hyzaar, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Hyzaar and have Acute myeloid leukaemia aggravated. It is created by eHealthMe based on reports of 15,569 people who have side effects when taking Hyzaar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
15,569 people reported to have side effects when taking Hyzaar.
Among them, 8 people (0.05%) have Acute myeloid leukaemia aggravated.
What is Hyzaar?
Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 16,215 Hyzaar users for its effectiveness, alternative drugs and more.
What is Acute myeloid leukaemia aggravated?
Acute myeloid leukaemia aggravated (serious acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 1,213 drugs and 503 conditions by eHealthMe.
Number of Hyzaar and Acute myeloid leukaemia aggravated reports submitted per year:

Time on Hyzaar when people have Acute myeloid leukaemia aggravated *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Acute myeloid leukaemia aggravated when taking Hyzaar *:
- female: 25 %
- male: 75 %
Age of people who have Acute myeloid leukaemia aggravated when taking Hyzaar *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Hyzaar *:
- Allegra: 4 people, 50.00%
- Zoloft: 1 person, 12.50%
- Vitamin D: 1 person, 12.50%
- Venclexta: 1 person, 12.50%
- Sinemet: 1 person, 12.50%
- Posaconazole: 1 person, 12.50%
- Lipitor: 1 person, 12.50%
- Lantus Solostar: 1 person, 12.50%
- Flaxseed: 1 person, 12.50%
- Fish Oil: 1 person, 12.50%
Common side effects people have besides Acute myeloid leukaemia aggravated *:
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 50.00%
Common conditions people have *:
- Type 2 Diabetes: 1 person, 12.50%
- Diabetes: 1 person, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Hyzaar and have Acute myeloid leukaemia aggravated?
Check whether Acute myeloid leukaemia aggravated is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Acute myeloid leukaemia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of hydrochlorothiazide; losartan potassium:
Alternative drugs to, pros and cons of Hyzaar:
- Hyzaar (16,215 reports)
Common Hyzaar side effects:
- High blood pressure: 1,095 reports
- Fatigue (feeling of tiredness): 1,022 reports
- Drug ineffective: 955 reports
- Weakness: 919 reports
- Dizziness: 888 reports
- Pain: 868 reports
- Headache (pain in head): 791 reports
Browse all side effects of Hyzaar:
a b c d e f g h i j k l m n o p q r s t u v w x y zAcute myeloid leukaemia aggravated treatments and more:
- Acute myeloid leukaemia aggravated (24 reports)
COVID vaccines that are related to Acute myeloid leukaemia aggravated:
- Acute myeloid leukaemia aggravated in Moderna COVID Vaccine
- Acute myeloid leukaemia aggravated in Pfizer BioNTech Covid Vaccine
- Acute myeloid leukaemia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Acute myeloid leukaemia aggravated:
- Cyclophosphamide: 2,241 reports
- Revlimid: 1,345 reports
- Cytarabine: 1,274 reports
- Prednisone: 1,256 reports
- Methotrexate: 1,212 reports
- Vidaza: 976 reports
- Cisplatin: 753 reports
- Lopurin: 593 reports
- Allopurinol: 593 reports
- Prednisolone: 570 reports
All the drugs that are associated with Acute myeloid leukaemia aggravated:
- Acute myeloid leukaemia aggravated (1,213 drugs)
Common conditions associated with Acute myeloid leukaemia aggravated:
- Multiple myeloma: 769 reports
- Breast cancer: 563 reports
- High blood pressure: 494 reports
- Primary myelofibrosis: 485 reports
- Non-hodgkin's lymphoma: 388 reports
- Ovarian cancer: 386 reports
All the conditions that are associated with Acute myeloid leukaemia aggravated:
- Acute myeloid leukaemia aggravated (503 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on hydrochlorothiazide; losartan potassium (the active ingredients of Hyzaar) and Hyzaar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Klonopin and Gastritis - now
- Dovonex and Stomatitis - a second ago
- Cymbalta and Diabetic Gastroparesis - 4 seconds ago
- Pentazocine and Hypotension - 5 seconds ago
- Coreg Cr and Demadex drug interaction - 11 seconds ago
- Prozac and Victoza drug interaction - 15 seconds ago
- Elaprase and Terminal State - 19 seconds ago
- Lorazepam and Stent Occlusion - 20 seconds ago
- Blephamide S.O.P. and Boniva drug interaction - 21 seconds ago
- Gentamicin and Superinfection - 22 seconds ago